AI assistant
Sending…
HALLIBURTON CO — Director's Dealing 2022
Jan 5, 2022
30269_dirs_2022-01-05_58ae4c4a-a4f2-4504-8262-3b9c3b504e81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HALLIBURTON CO (HAL)
CIK: 0000045012
Period of Report: 2022-01-03
Reporting Person: Pope Lawrence J (EVP Administration & CHRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-03 | Common Stock | A | 37629 | $23.99 | Acquired | 324080.405 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy Common Stock | $31.44 | 2028-12-05 | Common Stock (51100) | 51100 | Direct |
| Option to Buy Common Stock | $43.38 | 2027-12-06 | Common Stock (34300) | 34300 | Direct |
| Option to Buy Common Stock | $53.54 | 2026-12-07 | Common Stock (30500) | 30500 | Direct |
| Option to Buy Common Stock | $38.95 | 2025-12-02 | Common Stock (44500) | 44500 | Direct |
| Option to Buy Common Stock | $40.75 | 2024-12-03 | Common Stock (47400) | 47400 | Direct |
| Option to Buy Common Stock | $50.62 | 2023-12-04 | Common Stock (29400) | 29400 | Direct |
| Option to Buy Common Stock | $33.50 | 2022-12-05 | Common Stock (38500) | 38500 | Direct |
Footnotes
F1: Shares awarded pursuant to the Halliburton Company Stock and Incentive Plan. Said Plan provides for the surrender of common stock to the Issuer to satisfy withholding tax obligations.
F2: The closing price of Halliburton Company's Common Stock on the New York Stock Exchange on the January 3, 2022 grant date was $23.99.
More from HALLIBURTON CO
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 27